Current treatment methods for urologic dysfunction or pelvic pain are often focused on only one aspect of care, for example, the bladder epithelium or vaginal tissue. While these methods can provide some relief, it is when they are performed in conjunction with an array of other treatment modalities that we have found both increased patient satisfaction and symptom improvement. This presentation includes a discussion about many different therapies including medications, trigger point injections, and topical treatments.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:
• Identify two advantages to a multimodal approach to urologic dysfunction and pelvic pain.

Emily Dove-Medows MSN, CNM

Appearances